
Health Canada Approves Pembrolizumab/Chemotherapy for Unresectable, Advanced or Metastatic Pleural Mesothelioma
Health Canada has approved pembrolizumab (Keytruda) plus pemetrexed and platinum-based chemotherapy for the first-line treatment of adult patients with unresectable advanced or metastatic malignant pleural mesothelioma.1 The regulatory decision was based …